Table 2

 Clinical summary of 35 cases of steroid-treated temporal arteritis

CaseLength of artery (mm)Eye involvedAge (years)SexRaceESR(mm/h)Corticosteroid dosage (mg)Duration of treatment (days)Cumulative dose (mg)
AA, African American; Bx, ; C, Caucasian; ESR, erythrocyte sedimentation rate; F, Female; IV, intravenous; IVMP, Intravenous methylprednisolone; M, Male; NK, not known; OD, right eye; OS, left eye
116OD75FC96607420
210OS76FC10030390
315OD77FC5860603600
49OS64MCNK60452700
516OD60FC134605300
621OS75MC76605300
715OD82FC10040421680
88OD86FC1106016220
920OD62MCNK1003300
1023OD76FC112IVMP 100033000
1131OD71FCNK60905400
1212OS63FC1151004400
1315OS70FC22807560
147OD75MC99IVMP 100033000
15NKOS74FC58IVMP 100033000
1610OD71FC5360211260
1712OD79FC75604240
1820OD68FNKNKIVMP 1000×3 days, 100 6 weeks, 80 2 weeks608320
19NKOD69FC4540×3 days, 80×3 days6360
2035OS67MAANK6010600
2125OD76MC115805400
22NKOS66FNK81603180
2319OD74FC6607420
2414OS78MC60607420
2514OD80MC49Medrol dose 10 g pack 3 months before Bx3300
2616OS87MC10200 IV×2 days 80×5 days
7800
2716OS87MC4040×3 days 60×2 days
5240
2818OS67FC68010800
2915OD74MC38100×6 days Medrol dose pack (150 mg total)
7750
3015OD77MC476010600
319OS82FC125180900
3213OD80FCNKIVMP 1000 mg×3 days 8043080
3319OD80FCNK4012480
3422OD77FC85IVMP 1000 mg×3 days 80 mg×3 days
63240
3520OD89MCNK60×5 days, IVMP 1000 mg×3 days83300